Ultime notizie per Turning Point Brands (NYSE:TPB) Azioni

Turning Point Brands

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

I trend indicano un rischio significativo per alcuni titoli chiave che potrebbero influenzare le decisioni degli investitori nel 2025.

Imprevisto nel settore dei beni di consumo: 3 azioni a rischio crollo

Turning Point Brands Inc

BETMAKERS TECH GRP LTD by Betmakers Technology Group Ltd.

BetMakers Technology Group Ltd

WIIM

Tetra Technologies shares are trading higher following a Q1 adjusted EPS beat.

<a href="https://www.jnj.com/media-center/press-releases/johnson-johnson-receives-fda-approval-for-imaavytm-nipocalimab-aahu-a-new-fcrn-blocker-offering-long-lasting-disease-control-in-the-broadest-population-of-people-living-with-generalized-myasthenia-gravis-gmg">https://www.jnj.com/media-center/press-releases/johnson-johnson-receives-fda-approval-for-imaavytm-nipocalimab-aahu-a-new-fcrn-blocker-offering-long-lasting-disease-control-in-the-broadest-population-of-people-living-with-generalized-myasthenia-gravis-gmg</a>
&nbsp;
<h2>First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older IMAAVY delivered rapid and substantial reduction in immunoglobulin G (IgG) levels, one of the root causes of gMG, in both the adult and pediatric pivotal studies gMG patients taking IMAAVY demonstrated 20 months of lasting disease control and symptom relief in the pivotal Vivacity-MG3 study and ongoing open-label extension (OLE)</h2>
&nbsp;
&nbsp;
SPRING HOUSE, Pa., (April 30, 2025) – Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) today announced that the U.S. Food and Drug Administration (FDA) has approved IMAAVY&#x2122; (nipocalimab-aahu), a human FcRn-blocking monoclonal antibody, for the treatment of generalized myasthenia gravis (gMG). The approval, which follows <a href="https://www.jnj.com/media-center/press-releases/nipocalimab-granted-u-s-fda-priority-review-for-the-treatment-of-generalized-myasthenia-gravis-gmg">FDA Priority Review designation</a>, offers a new treatment option in a proven class with the potential for lasting disease control in the broadest population of people living with gMG (adults and pediatric patients 12 years of age and older who are anti-acetylcholine receptor [AChR] or anti-muscle-specific kinase [MuSK] antibody positive).1

Biotech

General

Johnson & Johnson Receives FDA Approval For IMAAVYTM, A New FcRn Blocker Offering Long-Lasting Disease Control In The Broadest Population Of People Living With Generalized Myasthenia Gravis

Despite recession fears looming, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) remains the preferred asset for asymmetric upside and may be primed for another move higher in the months ahead, <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45096202/eric-trump-advocates-for-crypto-says-banks-need-to-evolve-or-face-irrelevance">according to prominent commentators</a>.
What Happened: In a <a href="https://x.com/DTAPCAP/status/1917377996979159433">post</a> on X on April 30, Dan Tapiero, founder of DTAP Capital highlighted the decline in U.S. consumer expectations, now at 54.4.
This matches the 2009 financial crisis lows and stands below COVID-era panic levels; an ominous signal for the broader economy.
Tapiero warned that the Fed is &#8220;playing with fire&#8221; and argued that much lower rates and a weaker dollar will be necessary to offset growing fiscal drag. 
In that environment, fiat debasement could drive capital into Bitcoin.
Crypto trader Byzantine General added that Bitcoin is grinding against resistance with a neutral basis and little passive supply visible, implying potential for another upside breakout.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Neutral basis, keeps grinding against resistance, not much passive supply in the books, &#8230; Kinda looks like <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> wants to pop higher at least one more time. <a href="https://t.co/z8QSJh5sou">pic.twitter.com/z8QSJh5sou</a>
&mdash; Byzantine General (@ByzGeneral) <a href="https://twitter.com/ByzGeneral/status/1917289736395280685?ref_src=twsrc%5Etfw">April 29, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45079322/bitcoin-glued-to-95000-but-wednesday-inflation-data-could-spur-a-breakout">Bitcoin Glued To $95,000 But Wednesday Inflation Data Could Spur A Breakout</a>
Why It Matters: Economist and trader Alex Krüger <a href="https://x.com/krugermacro/status/1917086346109411725">said</a> the U.S. is entering a sharp economic slowdown that could turn into a full recession by the third quarter. 
While Trump's trade pause may soften some of the impact, the near-term market focus is on tariff developments and tech earnings.  
Payrolls data is seen as less relevant due to its lagging nature, whereas the upcoming FOMC meeting could be pivotal if Fed Chair Jerome Powell hints at earlier rate cuts. 
The near-term outlook favors risk assets amid easing trade tensions and a lack of major negative earnings shocks, though volatility remains high.
Krüger, who recently began de-risking, said Bitcoin remains his top pick over equities due to its dual nature as both a high-risk asset and a store of value. 
He flagged July 8, when Trump's 90-day tariff pause expires, as a major inflection point.
Although altcoins have already surged, Krüger cautioned against fear of missing out and emphasized maintaining discipline: "Markets may diverge wildly from fundamentals, stay level-headed regardless of political lean."
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45076518/bitcoin-is-a-commodity-like-gold-says-commerce-secretary-lutnick">Bitcoin Is A Commodity Like Gold, Says Commerce Secretary Lutnick</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Stays The Course At $95,000 But Recession Fears Linger

HRZN

Horizon Technology Finance shares are trading lower after the company reported Q1 financial results and missed its net and total investment income estimates.

Wabash National shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY25 guidance below estimates.

In the rollercoaster aftermath <a href="https://www.benzinga.com/topic/donald-trump">of Donald Trump'</a>s return to the Oval Office, equity markets have whipsawed with a blend of hope and havoc. 
But while headlines swirl with "uncertainty," "risk," and "tariffs," JPMorgan analyst Claudia K. Hueston isn't panicking. Instead, she sees what she calls a "rare opportunity to invest in core holdings" &#8211; a select club of bruised but not broken stocks she&#8217;s dubbing the "Fallen Angels."
According to Hueston's latest thematic deep dive, the market's mood is a cocktail of "apprehension and cautious optimism." But for investors willing to sift through the noise, she suggests there are hidden gems among the sectors hardest hit by policy shifts, trade friction and fears of a looming recession.
<h2 class="wp-block-heading">Meta, Broadcom, Amazon &#8211; &#8216;Fallen Angels&#8217; With Strong Fundamentals</h2>
The Fallen Angels, curated by JPMorgan's research team, aren't your average value plays. These are companies with "strong underlying fundamentals," "resilient business models," and leadership positions in their sectors &#8211; even if their stock prices have temporarily gone out of favor.
The key, according to Hueston, is finding stocks "with the ability to capitalize on long-term industry trends" while markets overreact to short-term noise. For those willing to navigate the chaos, these bruised leaders could be the surprise winners of Trump's next 100 days. Stocks that made it to the list include:
Take Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) for example. Though it&#8217;s weathered regulatory crosshairs and global trade tremors, JPMorgan's Doug Anmuth remains bullish, setting a $220 price target by the end of 2025. Amazon's scale, cloud dominance and relentless innovation keep it on the "Overweight" list.
Then there's Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), riding the AI hardware wave. With a $250 price target, analyst Harlan Sur sees the chipmaker as a tech titan capitalizing on long-term industry trends &#8211; precisely the kind of trait Hueston praises as a Fallen Angel.
And don't sleep on Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>). Despite previous volatility and investor angst around ad spending, Meta&#8217;s innovative services give it the ability to remain at the top of the social media heap. JPMorgan's $610 target underscores confidence in the company's monetization engine and AI roadmap.
Read Also: <a href="https://www.benzinga.com/25/04/45089384/cathie-wood-bets-against-mark-zuckerbergs-meta-ahead-of-crucial-earnings-report-loads-up-on-this-amazon-rival">Cathie Wood Bets Against Mark Zuckerberg&#8217;s Meta Ahead Of Crucial Earnings Report, Loads Up On This Amazon Rival</a>
<h2 class="wp-block-heading">Tesla, Apple Among &#8216;Most Negatively Impacted Stocks&#8217;</h2>
Hueston also flags the "most negatively impacted" stocks &#8211; those burdened with international exposure, heavy debt, or limited pricing power. 
Stocks like Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Apple Inc. (NASDAQ: AAPL) have seen investor sentiment sour amid tensions with China and regulatory overhangs. These companies, she warns, are swimming against the current in a market environment fraught with geopolitical risks and recession concerns.
But for the Angels? Hueston's message is clear: volatility is not a red flag &#8211; it's a runway. Investors who can stomach the turbulence may find themselves holding tomorrow's winners.
As Trump's policies continue to send ripples through the economy, Claudia Hueston says it best: "There are potential investment avenues for those willing to navigate the complexities."
The real question is &#8211; who's bold enough to buy the dip?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/media/25/04/45089307/trump-says-hes-already-ended-inflation-at-michigan-rally-held-to-mark-100-days-in-office-promises-to-protect-medicare-and-social-security-democrats-plan-senate-ba">Trump Says He&#8217;s &#8216;Already Ended Inflation&#8217; At Michigan Rally Held To Mark 100 Days In Office, Promises To Protect Medicare And Social Security — Democrats Plan Senate Barrage</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Analyst Ratings

Tech

AAPL

AMZN

AVGO

TSLA

Trump's Next 100 Days: These 'Fallen Angels' Are JPMorgan's Top Picks

Telsey Advisory Group analyst Joseph Feldman maintains Grocery Outlet Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GO#NASDAQ">GO</a>) with a Market Perform and maintains $16 price target.

Price Target

Telsey Advisory Group Maintains Market Perform on Grocery Outlet Holding, Maintains $16 Price Target

Following President Donald Trump&#8216;s dismissal of two federal labor board members, Federal Reserve Chair Jerome Powell is closely monitoring the situation, given its possible impact on his job security.
What Happened: The U.S. Supreme Court is set to rule on President Trump's attempt to fire two federal labor board members—Cathy Harris and Gwynne Wilcox—despite legal protections for their roles and it could set a precedent for the President&#8217;s authority over independent federal agencies, reported Reuters. 
Both Harris and Wilcox, appointed by former President Joe Biden, had years remaining in their terms when they were dismissed.
The case challenges whether congressional safeguards limiting presidential firings infringe on constitutional executive powers.
The removal of Harris and Wilcox, part of a broader government overhaul, has sparked legal challenges. Two federal judges blocked the dismissals, citing a 1935 Supreme Court precedent. The upcoming Supreme Court decision could clarify whether Trump has the authority to fire Federal Reserve officials.
Legal experts opine that if the Supreme Court strikes down removal protections for the two labor boards, it might carve out an exception to maintain the Federal Reserve&#8217;s independence. A ruling could be issued at any time.
SEE ALSO: <a href="https://benzinga.com/tech/25/04/45090992/mark-zuckerberg-warns-of-serious-disadvantage-as-chinas-data-center-blitz-could-let-deepseek-leapfrog-us-ai-" target="_blank" rel="noreferrer noopener">Mark Zuckerberg Warns Of &#8216;Serious Disadvantage&#8217; As China&#8217;s Data-Center Blitz Could Let DeepSeek Leapfrog US AI Labs</a>
Why It Matters: This situation comes amid a tense relationship between Trump and Powell. Trump, during his 100-day rally in Michigan, <a href="https://www.benzinga.com/news/25/04/45093252/trump-says-he-knows-much-more-than-fed-chair-jerome-powell-about-interest-rates">renewed attacks</a> on Powell and claimed to have superior knowledge about interest rates than the Fed Chair.
Previously,&nbsp;Trump backed off from <a href="https://www.benzinga.com/government/regulations/25/04/44977395/trump-backs-off-firing-powell-after-walmart-target-ceos-warn-him-of-empty-store-shelves">firing Powell</a> after warnings from the CEOs of Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) and Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) about potential financial chaos.
 Meanwhile, Economist Peter Schiff predicted that Trump would <a href="https://www.benzinga.com/news/25/04/45027556/after-powell-trumps-fed-nominee-will-be-a-loyal-soldier-says-peter-schiff-willing-to-sacrifice-the-dollar-create-inflation-as-needed">likely nominate</a> a highly dovish replacement for Powell, one willing to &#8220;sacrifice the dollar and create as much inflation as needed&#8221; to keep interest rates low. Notably, Powell has remained <a href="https://www.benzinga.com/markets/25/04/44943304/feds-jerome-powell-isnt-budging-on-rate-cut-despite-trumps-bashing-and-pressure-heres-why">steadfast </a>in his stance on interest rates, despite Trump&#8217;s criticism.&nbsp;
<ul>
<li>READ MORE: <a href="https://benzinga.com/markets/cryptocurrency/25/04/45095315/bitcoin-ethereum-xrp-dogecoin-turn-green-ahead-of-wednesdays-inflation-data" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Await Inflation, GDP Data &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Supreme Court's Upcoming Ruling On Trump's Dismissals To Decide Fate Of Fed Chair Powell's Job: Report

Needham analyst Kyle Peterson reiterates SoFi Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) with a Buy and maintains $20 price target.

Reiteration

SOFI

Needham Reiterates Buy on SoFi Technologies, Maintains $20 Price Target

As of April 30, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Sensient Technologies Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>)</h3>
<ul>
<li>On April 25, Sensient Technologies reported better-than-expected first-quarter financial results and raised its FY25 EPS forecast. &#8220;As expected, Sensient got off to a strong start in the first quarter of 2025, building on the momentum from the previous year. Our results are driven by solid volume growth and sales wins, particularly in natural colors. The quarter&#8217;s achievements underscore our ability to adapt in dynamic market conditions, and I am pleased to reaffirm our 2025 guidance,&#8221; said Paul Manning, Sensient&#8217;s Chairman, President, and Chief Executive Officer. The company's stock jumped around 27% over the past month and has a 52-week high of $94.64.</li>
<li>RSI Value: 85.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>SXT Price Action: Shares of Sensient jumped 4.6% to close at $94.34 on Tuesday.</li>
<li>Edge Stock Ratings: 87.99 Momentum score with Value at 54.19. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/sxt"><img loading="lazy" decoding="async" width="493" height="180" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30042127/image-227.png" alt="" class="wp-image-894312" style="width:414px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30042127/image-227.png 493w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/30042127/image-227-300x110.png 300w" sizes="(max-width: 493px) 100vw, 493px" /></a></figure>
<h3 class="wp-block-heading">Compass Minerals International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>)</h3>
<ul>
<li>On March 25, Compass Minerals announced cost structure reductions to align with current business needs. &#8220;Decisions such as these are never easy, but our board of directors and senior leadership team took a hard look at our cost structure and determined these actions were necessary to enable us to generate additional cash flow and accelerate our deleveraging,&#8221; said Edward C. Dowling Jr, president and CEO. The company's stock gained around 43% over the past month and <a href="https://www.benzinga.com/quote/CMP">has a 52-week high</a> of $15.82.</li>
<li>RSI Value: 80.7</li>
<li>CMP Price Action: Shares of Compass Minerals gained 2% to close at $13.26 on Tuesday.</li>
</ul>
Curious about other BZ Edge Rankings? Click here to discover <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">how similar stocks measure up</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45064976/top-3-industrials-stocks-which-could-rescue-your-portfolio-in-q2">Top 3 Industrials Stocks Which Could Rescue Your Portfolio In Q2</a> </li>
</ul>
Photo via Shutterstock

Top 2 Materials Stocks That May Fall Off A Cliff This Quarter

DTCK

Davis Commodities shares are trading higher after the company entered a strategic joint venture with a Malaysian agri-processor to produce and export to the Northeast Asian market.

SAGT

Sagtec Global shares are trading higher after the company reported a year-over-year increase in FY24 financial results.

Initial trial phase ("PoC 1") achieved key learnings and met all study objectives
Clinically meaningful pain reduction with 100% of responders achieving zero opioid use at 7 days post-procedure and 73% of responders remaining opioid free at 4-6 week follow-up
Company has initiated market expansion study ("PoC 2") of additional visceral cancers, and earlier stage pancreatic cancer, to begin in Q2 2025
Additional indications potentially double the addressable market beyond pancreatic cancer pain
&nbsp;

AMIX

Autonomix Medical Reports Outcomes In Initial Phase Of First-in-Human Proof-of-Concept Trial In Pancreatic Cancer Pain And Initiates Market Expansion Study for Visceral Cancer Pain

Needham analyst Ami Fadia reiterates Sage Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGE#NASDAQ">SAGE</a>) from Hold to Hold.

SAGE

Needham Reiterates Hold on Sage Therapeuticsto Hold

PPBT

Purple Biotech shares are trading higher after the company's CM24 showed up to a 90% reduction in the death risk for pancreatic cancer patients and announced it will commence a Phase 2b study.

Earnings

Sagtec Global FY24 EPS $0.14 Up From $0.09 YoY; Revenue $11.6M Up From $6.5M YoY

Ocean Power Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#NYSE">OPTT</a>) ("OPT" or the "Company"), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and more productive ocean operations and related power, data, and service solutions, today announced the shipment of a WAM-V&#xAE; 22' with autonomous capabilities designed to provide offshore surveys with 24/7 operational payloads for multiple days without requiring a return to base.

OPTT

Ocean Power Technologies Ships Autonomous WAM-V 22 For Multi-Day Offshore Surveys

CERo Therapeutics Holdings, Inc., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERO#NASDAQ">CERO</a>) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms, announces that TriStar Centennial Medical Center, through Sarah Cannon Research Institute (SCRI), in Nashville, Tennessee, is a clinical trial site for the Company's Phase 1 clinical of CER-1236. Collaborating with SCRI to advance cancer research, TriStar Centennial offers innovative clinical research trials for various disease indications. The trial is focused on patients with acute myeloid leukemia (AML), and patient enrollment is underway, with expected dosing of the first patient during the first half of 2025.&nbsp;

CERO

CERo Therapeutics Announces TriStar Centennial Medical Center As Clinical Trial Site For Phase 1 Clinical Of CER-1236

RCKY

Rocky Brands shares are trading higher after the company reported better-than-expected Q1 financial results.

Telsey Advisory Group analyst Joseph Feldman maintains Holley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLLY#NYSE">HLLY</a>) with a Outperform and maintains $4.5 price target.

HLLY

Telsey Advisory Group Maintains Outperform on Holley, Maintains $4.5 Price Target

Press Releases

Turning Point Brands to Host Third Quarter 2024 Conference Call

Turning Point Brands Declares Common Stock Dividend

Turning Point Brands Announces Third Quarter 2024 Results

Tucker Carlson Introduces ALP, A Revolutionary New Nicotine Pouch Company

ALP Pre-orders Demolish Expectations as ALP Officially Launches Online

Turning Point Brands to Host Q4 and Fiscal Year 2024 Conference Call

Turning Point Brands Increases Common Stock Dividend

Turning Point Brands Announces Fourth Quarter and Full Year 2024 Results

Nicokick and Northerner Named Preferred Online Partners for ALP, Expanding Access to Premium Nicotine Pouches

Turning Point Brands to Host Q1 Conference Call

British American Tobacco Industries, p.l.c. Common Stock ADR

British American Tobacco

Ispire Technology

Altria Group

Philip Morris International Inc Common Stock

Philip Morris Intl

RLX Technology Inc. American Depositary Shares, each representing the right to receive one (1) Class A ordinary share

Comments

Turning Point Brands

Notizie

Ultime notizie per Turning Point Brands (NYSE:TPB) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO